Ver registro no DEDALUS
Exportar registro bibliográfico

Metrics


Metrics:

Determination of urinary lithogenic parameters in murine models orthologous to autosomal dominant polycystic kidney disease (2014)

  • Authors:
  • USP affiliated authors: ONUCHIC, LUIZ FERNANDO - FM
  • USP Schools: FM
  • DOI: 10.1007/s00240-014-0664-1
  • Subjects: NEFROPATIAS; MUTAÇÃO GENÉTICA; ÁCIDO ÚRICO
  • Language: Inglês
  • Imprenta:
  • Source:
    • Título do periódico: Urolithiasis
    • ISSN: 2194-7228
    • Volume/Número/Paginação/Ano: v. 42, n. 4, p. 301-307, 2014
  • Acesso online ao documento

    Online accessDOI or search this record in
    Informações sobre o DOI: 10.1007/s00240-014-0664-1 (Fonte: oaDOI API)
    • Este periódico é de assinatura
    • Este artigo é de acesso aberto
    • URL de acesso aberto
    • Cor do Acesso Aberto: green
    Informações sobre o Citescore
  • Título: Urolithiasis

    ISSN: 2194-7228

    Citescore - 2017: 1.82

    SJR - 2017: 0.899

    SNIP - 2017: 1.273


  • Exemplares físicos disponíveis nas Bibliotecas da USP
    BibliotecaCód. de barrasNúm. de chamada
    FM2504624-10BCSEP 391 2014
    How to cite
    A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas

    • ABNT

      FERRAZ, Renato Ribeiro Nogueira; FONSECA, Jonathan M.; GERMINO, Gregory George; ONUCHIC, Luiz Fernando; HEILBERG, Ita Pfeferman. Determination of urinary lithogenic parameters in murine models orthologous to autosomal dominant polycystic kidney disease. Urolithiasis, Berlim, v. 42, n. 4, p. 301-307, 2014. Disponível em: < http://link.springer.com/article/10.1007%2Fs00240-014-0664-1 > DOI: 10.1007/s00240-014-0664-1.
    • APA

      Ferraz, R. R. N., Fonseca, J. M., Germino, G. G., Onuchic, L. F., & Heilberg, I. P. (2014). Determination of urinary lithogenic parameters in murine models orthologous to autosomal dominant polycystic kidney disease. Urolithiasis, 42( 4), 301-307. doi:10.1007/s00240-014-0664-1
    • NLM

      Ferraz RRN, Fonseca JM, Germino GG, Onuchic LF, Heilberg IP. Determination of urinary lithogenic parameters in murine models orthologous to autosomal dominant polycystic kidney disease [Internet]. Urolithiasis. 2014 ; 42( 4): 301-307.Available from: http://link.springer.com/article/10.1007%2Fs00240-014-0664-1
    • Vancouver

      Ferraz RRN, Fonseca JM, Germino GG, Onuchic LF, Heilberg IP. Determination of urinary lithogenic parameters in murine models orthologous to autosomal dominant polycystic kidney disease [Internet]. Urolithiasis. 2014 ; 42( 4): 301-307.Available from: http://link.springer.com/article/10.1007%2Fs00240-014-0664-1

    Referências citadas na obra
    Wilson PD, Goilav B (2007) Cystic disease of the kidney. Annu Rev Pathol 2:341–368
    Peters DJ, Breuning MH (2001) Autosomal dominant polycystic kidney disease: modification of disease progression. Lancet 358:1439–1444
    Grantham JJ, Chapman AB, Torres VE (2006) Volume progression in autosomal dominant polycystic kidney disease: the major factor determining clinical outcomes. Clin J Am Soc Nephrol 1:148–157
    Bajwa ZH, Sial KA, Malik AB, Steinman TI (2004) Pain patterns in patients with polycystic kidney disease. Kidney Int 66:1561–1569
    Eloi SRM, Nishiura JL, Heilberg IP (2010) Translation, cultural adaptation and application of a pain questionnaire for patients with polycystic kidney disease. J Bras Nefrol 32:386–399
    Nishiura JL, Neves RFCA, Eloi SRM et al (2009) Evaluation of nephrolithiasis in autosomal dominant polycystic kidney disease patients. Clin J Am Soc Nephrol 4:838–844
    Torres VE, Erickson SB, Smith LH et al (1988) The association of nephrolithiasis and autosomal dominant polycystic kidney disease. Am J Kidney Dis 11:318–325
    Levine E, Grantham JJ (1992) Calcified renal stones and cyst calcifications in autosomal dominant polycystic kidney disease: clinical and CT study in 84 patients. AJR Am J Roentgenol 159:77–81
    Grampsas SA, Chandhoke PS, Fan J et al (2000) Anatomic and metabolic risk factors for nephrolithiasis in patients with autosomal dominant polycystic kidney disease. Am J Kidney Dis 36:53–57
    Amar AD, Das S, Egan RM (1981) Management of urinary calculous disease in patients with renal cysts: review of 12 years of experience in 18 patients. J Urol 125:153–156
    Gambaro G, Fabris A, Puliatta D, Lupo A (2006) Lithiasis in cystic kidney disease and malformations of the urinary tract. Urol Res 34:102–107
    Piontek K, Menezes LF, Garcia-Gonzalez MA et al (2007) A critical developmental switch defines the kinetics of kidney cyst formation after loss of Pkd1. Nat Med 13:1490–1495
    Takakura A, Contrino L, Beck AW, Zhou J (2008) Pkd1 inactivation induced in adulthood produces focal cystic disease. J Am Soc Nephrol 19:2351–2363
    Takakura A, Contrino L, Zhou X et al (2009) Renal injury is a third hit promoting rapid development of adult polycystic kidney disease. Hum Mol Genet 18:2523–2531
    Torres VE, Harris PC (2009) Autosomal dominant polycystic kidney disease: the last 3 years. Kidney Int 76:149–168
    Grantham JJ, Mulamalla S, Swenson-Fields KI (2011) Why kidneys fail in autosomal dominant polycystic kidney disease. Nat Rev Nephrol 7:556–566
    Piontek KB, Huso DL, Grinberg A et al (2004) A functional floxed allele of Pkd1 that can be conditionally inactivated in vivo. J Am Soc Nephrol 15:3035–3043
    Ferraz RR, Baxmann AC, Ferreira LG et al (2006) Preservation of urine samples for metabolic evaluation of stone-forming patients. Urol Res 34:329–337
    Hallson PC, Rose GA (1974) A simplified and rapid enzymatic method for determination of urinary oxalate. Clin Chim Acta 55:29–39
    Holt C, Cowley DM, Chalmers AH (1985) Rapid estimation of urinary citrate by use of a centrifugal analyzer. Clin Chem 31:779–780
    Fossati P, Prencipe L, Berti G (1980) Use of 3,5-dichloro-2-hydroxybenzenesulfonic acid/4-aminophenazone chromogenic system in direct enzymic assay of uric acid in serum and urine. Clin Chem 26:227–231
    Strufaldi B (1987) Prática de bioquímica clínica. Faculdade de Ciências Farmacêuticas da Universidade de Sao Paulo, Sao Paulo
    Macfate RP, Cohn C, Eichelberger L, Cooper JA (1954) Symposium on azotemia. Am J Clin Pathol 24:511–571
    Fonseca JM, Bastos AP, Amaral AG, et al. (2014) Renal cyst growth is the main determinant for hypertension and concentrating deficit in Pkd1-deficient mice. Kidney Int [Epub ahead of print]
    Torres VE, Wilson DM, Hattery RR, Segura JW (1993) Renal stone disease in autosomal dominant polycystic kidney disease. Am J Kidney Dis 22:513–519
    Ogbron MR, Sareen S, Prychitko J et al (1997) Altered organic anion and osmolyte content and excretion in rat polycystic kidney disease: an NMR study. Am J Physiol 272:F63–F69
    Tanner GA, Tanner JA (2003) Dietary citrate treatment of polycystic kidney disease in rats. Nephron Physiol 93:P14–P20
    Kelly S, Delnomdedieu M, Oliverio M et al (2001) Diabetes insipidus in uricase-deficient mice: a model for evaluating therapy with poly(ethylene glycol)-modified uricase. J Am Soc Nephrol 12:1001–1009
    Torres VE, Keith DS, Offord KP et al (1994) Renal ammonia in autosomal dominant polycystic kidney disease. Kidney Int 45:1745–1753
    Bastos AP, Piontek K, Silva AM et al (2009) Pkd1 haploinsufficiency increases renal damage and induces microcyst formation following ischemia/reperfusion. J Am Soc Nephrol 20:2389–2402
    Khan SR (2010) Nephrocalcinosis in animal models with and without stones. Urol Res 38:429–438
    Bushinsky DA, Asplin JR, Grynpas MD et al (2002) Calcium oxalate stone formation in genetic hypercalciuric stone-forming rats. Kidney Int 61:975–987
    Jiang Z, Asplin JR, Evan AP et al (2006) Calcium oxalate urolithiasis in mice lacking anion transporter Slc26a6. Nat Genet 38:474–478